News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
422,345 Results
Type
Article (27152)
Company Profile (60)
Press Release (395130)
Multimedia
Podcasts (32)
Webinars (7)
Section
Business (115006)
Career Advice (461)
Deals (19338)
Drug Delivery (52)
Drug Development (50832)
Employer Resources (47)
FDA (12948)
Job Trends (8767)
News (203863)
Policy (21199)
Tag
Academia (1789)
Accelerated approval (6)
Adcomms (9)
Allergies (97)
Alliances (30910)
ALS (79)
Alzheimer's disease (949)
Antibody-drug conjugate (ADC) (128)
Approvals (13149)
Artificial intelligence (259)
Autoimmune disease (52)
Automation (6)
Bankruptcy (148)
Best Places to Work (7045)
BIOSECURE Act (5)
Biosimilars (83)
Biotechnology (39)
Bladder cancer (109)
Brain cancer (31)
Breast cancer (346)
Cancer (2597)
Cardiovascular disease (214)
Career advice (420)
Career pathing (14)
CAR-T (111)
CDC (25)
Cell therapy (316)
Cervical cancer (22)
Clinical research (44800)
Collaboration (748)
Compensation (240)
Complete response letters (17)
COVID-19 (1615)
CRISPR (29)
C-suite (354)
Cystic fibrosis (56)
Data (3429)
Decentralized trials (2)
Denatured (19)
Depression (66)
Diabetes (291)
Diagnostics (3856)
Digital health (23)
Diversity (6)
Diversity, equity & inclusion (13)
Drug discovery (87)
Drug pricing (82)
Drug shortages (22)
Duchenne muscular dystrophy (120)
Earnings (42145)
Editorial (25)
Employer branding (6)
Employer resources (46)
Events (56977)
Executive appointments (589)
FDA (14848)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (4)
Frontotemporal dementia (6)
Funding (686)
Gene editing (62)
Generative AI (13)
Gene therapy (224)
GLP-1 (524)
Government (3201)
Grass and pollen (5)
Guidances (234)
Healthcare (12549)
HIV (30)
Huntington's disease (16)
IgA nephropathy (44)
Immunology and inflammation (74)
Immuno-oncology (4)
Indications (42)
Infectious disease (1735)
Inflammatory bowel disease (106)
Inflation Reduction Act (7)
Influenza (48)
Intellectual property (101)
Interviews (40)
IPO (7881)
IRA (22)
Job creations (1983)
Job search strategy (387)
Kidney cancer (10)
Labor market (31)
Layoffs (195)
Leadership (7)
Legal (4251)
Liver cancer (68)
Longevity (6)
Lung cancer (423)
Lymphoma (186)
Machine learning (10)
Management (17)
Manufacturing (244)
MASH (95)
Medical device (13278)
Medtech (13298)
Mergers & acquisitions (11939)
Metabolic disorders (682)
Multiple sclerosis (89)
NASH (11)
Neurodegenerative disease (98)
Neuropsychiatric disorders (19)
Neuroscience (1547)
NextGen: Class of 2025 (4018)
Non-profit (2846)
Now hiring (29)
Obesity (284)
Opinion (88)
Ovarian cancer (105)
Pain (114)
Pancreatic cancer (107)
Parkinson's disease (141)
Partnered (15)
Patents (204)
Patient recruitment (239)
Peanut (40)
People (37469)
Pharmaceutical (15)
Pharmacy benefit managers (15)
Phase I (12834)
Phase II (19355)
Phase III (15926)
Pipeline (1697)
Policy (117)
Postmarket research (1761)
Preclinical (4100)
Press Release (19)
Prostate cancer (144)
Psychedelics (23)
Radiopharmaceuticals (169)
Rare diseases (326)
Real estate (3240)
Recruiting (18)
Regulatory (16174)
Reports (20)
Research institute (1665)
Resumes & cover letters (49)
Rett syndrome (9)
RNA editing (3)
RSV (34)
Schizophrenia (103)
Series A (111)
Series B (86)
Service/supplier (3)
Sickle cell disease (34)
Special edition (6)
Spinal muscular atrophy (103)
Sponsored (16)
Startups (2322)
Stomach cancer (10)
Supply chain (54)
Tariffs (22)
The Weekly (13)
Vaccines (494)
Venture capital (18)
Weight loss (186)
Women's health (28)
Worklife (4)
Date
Today (116)
Last 7 days (478)
Last 30 days (1706)
Last 365 days (17773)
2025 (14856)
2024 (21007)
2023 (24075)
2022 (32786)
2021 (35121)
2020 (34388)
2019 (29940)
2018 (23046)
2017 (20511)
2016 (19611)
2015 (23127)
2014 (17578)
2013 (14710)
2012 (15832)
2011 (16248)
2010 (14815)
Location
Africa (405)
Alabama (28)
Alaska (2)
Arizona (149)
Arkansas (10)
Asia (35457)
Australia (5159)
California (4950)
Canada (1811)
China (713)
Colorado (234)
Connecticut (250)
Delaware (204)
Europe (56135)
Florida (830)
Georgia (196)
Idaho (35)
Illinois (495)
India (38)
Indiana (336)
Iowa (7)
Japan (292)
Kansas (86)
Kentucky (17)
Louisiana (12)
Maine (29)
Maryland (833)
Massachusetts (3371)
Michigan (135)
Minnesota (398)
Mississippi (3)
Missouri (72)
Montana (18)
Nebraska (18)
Nevada (60)
New Hampshire (69)
New Jersey (1756)
New Mexico (9)
New York (1412)
North Carolina (740)
North Dakota (4)
Northern California (2274)
Ohio (186)
Oklahoma (7)
Oregon (26)
Pennsylvania (1213)
Puerto Rico (9)
Rhode Island (32)
South America (572)
South Carolina (44)
Southern California (1970)
Tennessee (108)
Texas (873)
United States (19353)
Utah (172)
Virginia (124)
Washington D.C. (49)
Washington State (327)
West Virginia (4)
Wisconsin (53)
Wyoming (1)
422,345 Results for "icecure medical ltd".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
IceCure Medical’s ProSense® Cryoablation Granted FDA Marketing Authorization for Treatment of Low-Risk Breast Cancer in Women Aged 70 and Above: Significant Development in Giving Women with Breast Cancer Minimally Invasive Care
October 5, 2025
·
9 min read
Business
IceCure Medical Reports Full Year 2023 Financial Results
IceCure Medical Ltd. today reported sales as of and for the twelve months ended December 31, 2023.
April 3, 2024
·
17 min read
Business
IceCure Medical Maintains Positive Momentum and Reports Sales Growth for Cryoablation System in First Quarter of 2024
IceCure Medical Ltd. today reported financial results as of and for the three months ended March 31, 2024.
May 28, 2024
·
17 min read
IceCure Medical to Provide Overview and Share Recent Progress at Northland Capital Markets Virtual Growth Conference on June 25, 2024
IceCure Medical Ltd. today announced the Company’s management, will participate in the Northland Capital Markets Virtual Growth Conference on Tuesday, June 25, 2024.
June 18, 2024
·
5 min read
U.S. Food and Drug Administration Grants Regulatory Clearance to IceCure for Next-Gen XSense™ Cryoablation System with CryoProbes
IceCure Medical Ltd. (NASDAQ: ICCM) (“IceCure”, “IceCure Medical” or the “Company”) today announced it has received marketing authorization from the United States Food and Drug Administration (the “FDA”) for its next-generation single probe cryoablation system, the XSense™ Cryoablation System with CryoProbes.
July 1, 2024
·
4 min read
Business
IceCure Medical to Report First Quarter 2024 Financial & Operational Results on May 28, 2024
IceCure Medical Ltd. announced today that it will issue a press release containing its financial and operational results as of and for the three months ended March 31, 2024 before the Nasdaq Stock Market opens on Tuesday, May 28, 2024.
May 21, 2024
·
3 min read
Business
IceCure Medical to Report 2023 Full Year Financial & Operational Results on April 3, 2024
IceCure Medical Ltd. (Nasdaq: ICCM) (“IceCure” or the “Company”) today announced that it will issue a press release with its financial and operational results as of and for the twelve months ended December 31, 2023 before the Nasdaq Stock Market opens on Wednesday, April 3, 2024.
March 27, 2024
·
4 min read
Business
IceCure Medical to Report First Quarter 2024 Financial & Operational Results on May 28, 2024 - May 21, 2024
IceCure Medical Ltd. announced today that it will issue a press release containing its financial and operational results as of and for the three months ended March 31, 2024 before the Nasdaq Stock Market opens on Tuesday, May 28, 2024.
May 21, 2024
·
3 min read
Positive Data from IceCure’s Kidney Cancer Clinical Study Presented at Interventional Radiology Conference: Minimally Invasive Approach Results in Shorter Hospitalization and Minor Impact on Renal Function
IceCure Medical Ltd. (Nasdaq: ICCM) (“IceCure”, “IceCure Medical” or the “Company”) today announced that data from an interim analysis of its ICESECRET kidney cancer trial were presented at the 3rd Annual Israeli Conference on Interventional Radiology in Tel Aviv, Israel on June 10, 2024.
June 12, 2024
·
5 min read
FDA to Convene Advisory Panel for Review of IceCure’s De Novo Marketing Clearance Request for ProSense®, Decision Expected Early 2025; Aligns with Commercial Readiness Plan
IceCure Medical Ltd. (Nasdaq: ICCM) (“IceCure”, “IceCure Medical” or the “Company”) today announced the U.S. Food and Drug Administration (“FDA”) will convene a Medical Device Advisory Committee for a panel meeting (the “Advisory Panel”) to obtain independent expert advice on scientific, technical, and policy matters related to ProSense® to help the FDA make a sound decision.
June 4, 2024
·
6 min read
1 of 42,235
Next
